Is That Really Behçet's? When Common Medications Mimic Rare Diseases
"A Case Study: How Methotrexate Side Effects Can Resemble Behçet's Disease, Leading to Diagnostic Confusion"
Methotrexate (MTX) is a medication widely used to treat various conditions, including psoriasis, rheumatoid arthritis, and certain types of cancer. It works by interfering with DNA synthesis, which helps to slow down the growth of rapidly dividing cells. This makes it effective in managing autoimmune diseases where the body's immune system attacks its own tissues.
Like all medications, MTX can cause side effects. While many are well-documented—such as nausea, fatigue, and hair loss—some are less common and can even mimic the symptoms of other diseases. This can lead to confusion and potentially delay the correct diagnosis. This case study sheds light on one such instance, where MTX side effects closely resembled Behçet's disease.
Behçet's disease is a rare and complex condition characterized by inflammation of blood vessels throughout the body. This can lead to a variety of symptoms, including mouth sores, genital sores, eye inflammation (uveitis), and skin lesions. Because these symptoms can also occur in other conditions, diagnosing Behçet's disease can be challenging.
Methotrexate Can Mimic Behçet’s
Methotrexate is used in treating several inflammatory and cutaneous diseases, but its adverse effects can complicate diagnosis. A reported patient developed oral, vaginal, and lower-leg lesions, creating a differential diagnosis of Behçet’s disease versus cutaneous methotrexate effects. Conventional intestinal Behçet’s treatments include 5-aminosalicylic acids, systemic corticosteroids, and immunosuppressive agents such as thiopurines, while long-term corticosteroid use may lead to steroid dependency and resistance.
An Unusual Adverse Effect
Methotrexate is an antimetabolite that interferes with DNA synthesis and has been used for moderate to severe psoriasis, atopic dermatitis, and other cutaneous diseases. Earlier reports had documented adverse effects including cutaneous ulcerations, but multifocal mucosal ulceration mimicking Behçet’s disease had not been reported in the cited case literature. Methotrexate was also presented as a therapeutic alternative in Behçet’s disease in an abstract by Retuerto-Guerrero and colleagues.
The Case: MTX Side Effects Mimicking Behçet's Disease
A 63-year-old woman with a history of necrotizing scleritis (a severe inflammatory condition affecting the eye) was being treated with methotrexate. Shortly after starting the medication, she developed several alarming symptoms: painful ulcers in her mouth and genital area, and purplish, crusted patches on her legs. These symptoms bore a striking resemblance to Behçet's disease, prompting her doctors to investigate further.
- Symptom Evaluation: Doctors carefully assessed the specific symptoms, noting the presence and characteristics of the ulcers and skin lesions.
- Laboratory Tests: Blood tests were conducted to look for markers of inflammation, immune system activity, and potential causes of the symptoms. Notably, the patient tested positive for HLA-B51, a genetic marker associated with Behçet's disease. However, other tests, such as the pathergy test (a skin reactivity test), were negative.
- Histopathology: A biopsy of the skin lesions was performed to examine the tissue under a microscope. The results showed some features suggestive of drug-induced reactions but lacked the specific signs of vasculitis (blood vessel inflammation) typically seen in Behçet's disease.
- Medication Review: Doctors carefully reviewed the patient's medication list and considered the possibility that MTX could be causing the symptoms.
Recent Evidence on Drug-Related Ulcers
A systematic review of management options for low-dose methotrexate-induced oral ulcers began with 66 articles and selected 30 for inclusion assessment. A separate report described oral-mucosal ulcerations and psoriatic plaques in a patient who had used methotrexate incorrectly. A review of drug-induced oral reactions identified nonsteroidal anti-inflammatory drugs and beta-blockers as the most common drugs associated with oral lichen planus.
Rare but Recognized Skin Reactions
Cutaneous adverse reactions to methotrexate are described as uncommon, but reported manifestations include skin ulcerations, necrosis, erosions of psoriatic plaques, and bullous acral erythema. The cited case report states that development of skin ulceration had been reported in a small number of patients. However, multifocal mucocutaneous involvement resembling Behçet’s disease was described as not previously reported in that literature.
Methotrexate’s Psoriasis Record
Methotrexate has a 40-year track record in psoriasis treatment. The cited review reports that it has been effective for psoriasis cases refractory to other intensive treatments. That established therapeutic history contrasts with the diagnostic confusion that can arise when methotrexate-related lesions resemble another disease.
Key Takeaways: What This Case Means for You
This case highlights the importance of recognizing that medications can sometimes cause unexpected side effects that mimic other diseases. While this particular scenario is rare, it underscores the need for careful monitoring of patients on MTX and other drugs with the potential for unusual reactions. Open communication between patients and their healthcare providers is essential for early detection and appropriate management of any adverse effects. If you're experiencing new or worsening symptoms while taking MTX, don't hesitate to discuss them with your doctor.